Source:http://linkedlifedata.com/resource/pubmed/id/16825021
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-7-7
|
pubmed:abstractText |
Hypoalbuminemia and muscle atrophy are frequently found in patients with chronic kidney disease (CKD) and patients being treated by dialysis. These abnormalities are usually attributed to malnutrition, meaning that they are caused by an inadequate diet. However, the evidence indicates that malnutrition is rarely the mechanism causing loss of protein stores. Instead, low values of serum albumin are closely related to the presence of inflammation and loss of muscle mass is attributable to activation of specific proteases. In uremic rodents and patients, the initial step in the loss of muscle protein is an activation of caspase-3. This cleaves the complex structure of muscle, and its action can be detected by the presence of a characteristic 14-kDa actin fragment in the insoluble fraction of muscle. The second step in uremia-induced loss of muscle protein is an activation of the ubiquitin-proteasome system, which rapidly degrades proteins released by caspase-3 cleavage of muscle proteins. Activation of both caspase-3 and the ubiquitin-proteasome system occur when there is suppression of the cellular signaling pathway activated by insulin/insulinlike growth factor 1, the phosphatidylinositol 3-kinase/Akt pathway. A potential therapeutic target for preventing loss of muscle protein is to stimulate activity of this signaling pathway.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CASP3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/Muscle Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1532-8503
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
208-11
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16825021-Animals,
pubmed-meshheading:16825021-Caspase 3,
pubmed-meshheading:16825021-Caspases,
pubmed-meshheading:16825021-Enzyme Activation,
pubmed-meshheading:16825021-Humans,
pubmed-meshheading:16825021-Kidney Failure, Chronic,
pubmed-meshheading:16825021-Malnutrition,
pubmed-meshheading:16825021-Muscle Proteins,
pubmed-meshheading:16825021-Muscular Atrophy,
pubmed-meshheading:16825021-Peptide Hydrolases,
pubmed-meshheading:16825021-Proteasome Endopeptidase Complex,
pubmed-meshheading:16825021-Renal Dialysis,
pubmed-meshheading:16825021-Signal Transduction,
pubmed-meshheading:16825021-Ubiquitin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure.
|
pubmed:affiliation |
Nephrology Division, Baylor College of Medicine, Houston, TX 77030, USA. mitch@bcm.edu
|
pubmed:publicationType |
Journal Article,
Review
|